Riskpilot← Back to searchSign inGet full accessPS Pharma AB
ABActiveOrg 5592645252Ljungslättsgatan 7 B Lgn 1103Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
+92% vs 2023
Equity ratio
-522.7%
Financial strength
Net profit 2024
SEK -11K
+91% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +92% |
| Net profit | SEK -11K | +91% |
| Total assets | SEK 22K | -72% |
| Equity | SEK -115K | -11% |
| Employees | 0 | — |
Legal name
PS Pharma AB
Org number
5592645252
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
22 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska vara verksam inom handel, import, export av: djurfoder, djurmedicin, läkemedel, kosmetika, kemtekniska produkter, livsmedel, bilar, lastbilar, bussar, bildelar, maskindelar inom livsmedelsindustri samt handel och förvaltning av fast och lös egendom. Bedriva byggnadsverksamhet samt inköp och försäljning av därmed tillhörande produkter och maskiner. Bolaget skall bedriva personaluthyrning, rekrytering, entreprenader, konsultverksamhet inom personalområdet. Äga och förvalta fastigheter och värdepapper och därmed förenlig verksamhet.
Address
Ljungslättsgatan 7 B Lgn 1103
Email
pouya.sharif@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 983 | 726 | 304 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | 182 | 250 | −130 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 182 | 250 | −130 | −11 |
| Net financials | — | 1 | 1 | — |
| Profit before tax | 182 | 251 | −129 | −11 |
| Tax | −39 | −52 | −0 | −0 |
| Net profit | 143 | 199 | −129 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 187 | 448 | 79 | 22 |
| Equity | 168 | 367 | −104 | −115 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 19 | 82 | 182 | 136 |
| Total debt | 19 | 82 | 182 | 136 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20212024
Equity ratio
-522.7%
This company
38.2%
Market median
-1468% vs market
20212024
Return on equity
-1100000.0%
This company
18.4%
Market median
-5978361% vs market
20212024
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PS Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pouya Sharif | Chief Executive Officer | 0 companies |
| Habibollah Sharif | Deputy Board Member | 0 companies |
| Sina Sharif | Deputy Board Member | 0 companies |